Strategy engagement · adversarially verified · 3 rounds

Five Strategies: From −$16M to Break-Even to +$20M

Eighteen strategies entered. Five survived. None of them lied.

The mandate: find five distinct paths from a −$16M/yr operating loss to break-even and on toward +$20M — spanning the full option space from DTC telehealth to acute + hospice + oncology + ambulatory. Nine strategy archetypes were built by independent teams, then attacked by a three-lens investment panel (financial realism, market/competitive response, regulatory/execution). Eight of nine failed round one. Survivors were repaired against the specific objections or replaced — across three rounds — until five stood. What survived is honest: no plan that claims +$20M fast survived review.

The five The Tesla answer →

Baseline: client-stated −$16M/yr (public IRS-990 FY2024 showed −$8.6M; planned to the harder number). Full 25,000-word engagement: Five_Strategies_Breakeven_to_20M.md on Downloads.

Read this first

1The honest numbers

FY2029
base-case break-even (P50: FY2030) — the funded portfolio
+$8–12M
operating income by FY2031–33 — top-quartile (2–3%) for a community hospital
+$20M
real but conditional: needs 2 of 3 gated engines to pay; FY2034–36 at ~35–50% probability
~$40–45M
external capital over 4 yrs, each source counted once — the balance sheet funds nothing
The central finding The five strategies are not five choices — they are one turnaround counted five times, one Arrowhead deal structured three ways, one senior-risk option designed twice, and one externalization idea in two vehicles, all bidding for the same three capital sources and the same four-workstream management ceiling. The portfolio job is deduplication, not selection: fund one ops engine (RedlandsOS), one physician chassis (friendly-PC/MSO/CIN), one ambulatory engine (buy-don't-build recaps), and carry two options at zero (PHN senior risk, playbook externalization).
Why no strategy "just gets" +$20M A +$36M swing is ~5 points of margin on $407M revenue — top-decile for any community hospital in America. The panel killed every version that pretended otherwise (the "Glass Hospital" surgical-destination play died three times). The strategies that survived either state a lower honest ceiling, or gate their +$20M on named, priced options with explicit probabilities. That is what makes this plan bankable rather than aspirational.
Survived the panel

2The five strategies

Ranked by the managing partner (best risk-adjusted path first). Panel scores show each lens: Financial / Market / Execution — a strategy passed with the financial lens viable plus 2-of-3 overall.

Rank 1 · consumer sleeve + physician alliance B−

Terracina, Priced to Contract — + The Independent Alliance

The escalation-layer consumer product (telehealth that can actually admit you) at honest scale, moved as one board motion with its real engine: the SB351-protected alliance of the corridor's independent physicians (CIN/MSO + PHN's ~54k lives + ASC JV + Pass corridor).

Break-even
FY2029 (Yr 3)
+$20M
FY2033–34, success case (~40–50%); base plateaus +$8–10M
Steady margin
~4.5% success case
Capital
$14–16M staged (venture sleeve only $2M, contract-gated)
Financial ✓60Market ✗62Execution ✓60 — the only strategy whose base and success cases live in the same decade as the mandate.
Rank 2 · ambulatory platform, re-underwritten B

Mothership & Fleet 3.0 — Turnaround First, Buy Don't Build

Commit the ~$20M-swing core turnaround as the base case, and buy — never build — minority stakes in the surgeons' own existing ASCs (the panel-verified fact: Arrowhead already owns its surgery center). Every market failure mode degrades to a still-breakeven fallback.

Break-even
Yr 4 (FY2030), with one CMIR delay already priced in
+$20M
Ceiling below +$20M in any bankable window; committed plan +$1–2M by Yr 7
Steady margin
~0.4% consolidated (equity-method JV income)
Capital
$55–60M program; RCH cash $24–27M phased
Financial ✓60Market ✓70Execution ✓62 — highest panel confidence in the set; the only arithmetically clean bridge in its family.
Rank 3 · the mandatory base layer B (as infrastructure)

RedlandsOS — The AI-Native Lean Hospital

Rebuild revenue cycle, patient flow, staffing, back office, and supply chain AI-first — a ~$19M gross swing on the $415M cost base without touching the bedside — then license the audited playbook to America's 400+ money-losing independent hospitals (Ensemble precedent: $1.2B for 51%).

Break-even
FY2029–30 (−$16M → −$12M → −$4M → 0)
+$20M
Says it plainly: standalone ceiling ~+$3.3M (band $0–6M) — the enabler, not the endgame
Steady margin
~0.8% — from −3.9% to the national median
Capital
$28M: vendor at-risk + philanthropy + NewCo sponsor equity + IT financing
Financial ✓60Market ✗72Execution ✓60 — not a path to +$20M and says so; but the highest risk-adjusted dollars anywhere in the set, and competition-proof (no one can block RCH from cutting its own costs).
Rank 4 · senior risk, earned not assumed C+

SilverPass: Earn the Right

Standalone break-even by 2030 on RCH's own P&L first — then exercise a severable, partner-funded senior global-risk option built on the engagement's single most valuable insight: RCH owns at ~50¢ marginal cost the hospital days that Oak Street, Cano, CareMax, and agilon all died paying retail for.

Break-even
2030 standalone (±$1M by 2029)
+$20M
Plan of record +$6.1M by 2034–35; full gated build ~2040 — shown, not underwritten
Steady margin
~1.3% consolidated at plan of record
Capital
$69M committed ($39M bridge + $30M NewCo operator capital)
Financial ✓57Market ✓55Execution ✓60 — the only strategy passing all three lenses; its internalized-Part-A insight powers the portfolio's senior-risk option.
Rank 5 · the shared command center C−

Redlands Unbound 2.0 — Fix the Core, Share the Center

Run the hospital smaller and smarter from one 24/7 command center — proven on RCH's own P&L first — then share it at cost-plus through a member-owned cooperative of small hospitals (Avel-style). The most honestly-architected of the five, and still dominated on every axis by RedlandsOS.

Break-even
Yr 4 (FY2030) hospital core
+$20M
Ceiling stated plainly: +$1–2M planning case; ~+$5M conditional by Yr 7–8
Steady margin
~0.3% consolidated
Capital
$22M staged & gated
Financial ✓55Market ✗68Execution ✓55 — absorbed into the portfolio as the command-center operating hub, not funded standalone.
What died — and why that matters The graveyard is as informative as the survivors: the Glass Hospital (transparent-price national surgical destination) failed three consecutive rounds — the employer-travel demand never penciled at Redlands' cost base. The original DTC consumer/longevity vertical survived only after shrinking to a +$1–2M "escalation sleeve" with $2M of contract-gated capital — a Hims/Hers-style national brand was judged unwinnable against pure-plays with 100× the marketing budget. The premium-flip payvider and the 5/50 serious-illness continuum died on capital reality and Knox-Keene timelines. Round log: 9 developed → 1 passed; 5 repaired → 2 total; 4 repaired → 5 total.
The pull-away move

3The Tesla answer: it's a stack, not a strategy

Every pretender to the pull-away claim died in panel. The honest answer: no single strategy is the Tesla — the Tesla move is a stack, and it only matures at replication.

Layer 1 · RedlandsOS The audited AI-native cost structure — three years of hospital-specific workflow libraries, denial taxonomies, staffing models, and CFO-verified benefit realization at community scale. Copyable software; uncopyable track record.
Layer 2 · The Independent Alliance An SB351-protected coalition of the 188-group independent bench, PHN's ~54k lives, and Arrowhead's surgical franchise — around the only independent full-stack hospital in the corridor. Optum legally cannot lead it (it's what the physicians are fleeing); Kaiser is closed by design; LLU can't price it.
Layer 3 · Internalized Part A The senior-risk chassis: RCH owns at ~50¢ marginal cost the hospital days that Oak Street, Cano, CareMax, and agilon all died paying retail for. Hospital-anchored global risk is the version of the model that can actually work.
Why the stack pulls away Each layer alone is copyable operational excellence. Stacked, they create a position none of the four named predators can occupy — ownership identity + regulatory position + a three-year audited execution dataset — assets a copycat cannot buy in 36 months with unlimited software budget. And the national vision matures at replication: if the stack works at RCH, the chassis — AI-native ops × alliance economics × hospital-anchored senior risk — franchises to the 400+ money-losing independent hospitals in America. That's how a 211-bed hospital in Redlands moves the health of a nation: not by getting bigger, but by proving the model every independent can copy — from us, not from Optum.
Board decision memo

4The funded portfolio — what to actually do

Fund once, count once

  • One ops engine: RedlandsOS at full spec (~$15–17M net run-rate swing), absorbing the command center and every overlapping restructuring line from the other four plans. One transformation office; CFO sign-off on every claimed dollar.
  • One physician chassis: friendly-PC / MSO / CIN — built once, serves everything (alliance, employer-direct, senior risk).
  • One ambulatory engine: buy-don't-build — recapitalize Arrowhead's existing ASC at Track-B economics; GI recap gated on a live LOI.
  • Two options carried at ZERO: the PHN senior global-risk book (gate decision FY2030, underwritten at realized-V28 economics with internalized Part A) and playbook externalization (RedlandsOS NewCo or co-op, Year 3+).

Gate Zero — next 90 days, before any capital moves

  • Read the master trust indenture (it conditions all receivables-based liquidity)
  • Confirm AB 869/seismic filing status; price the minimum-compliant footprint
  • Verify unrestricted cash; run the 340B/DSH model before any OB decision
  • Open the Arrowhead/AASC diligence window
  • Stand up the transformation office with benefit-realization authority

What we stop doing

  • Staffing 211 beds (consolidate to a census-derived ~165–175, reconciled to the seismic footprint)
  • Greenfield ASC construction; all pre-contract capex
  • Registry/traveler dependence as a permanent posture
  • Marketing against the structurally locked 70% of leakage
  • The consumer longevity membership; executive health (conceded to LLU)
  • More than four concurrent major workstreams — by board covenant
Tripwires — pre-agreed, automatic If FY2029 standalone operating income is worse than −$4M, or the CMS 3-star and stroke-mortality gates miss, the pre-agreed banker-run affiliation process opens automatically. The board is buying a funded break-even with two priced options on top-quartile performance — and should reject any future version of this plan in which a gated option has quietly become load-bearing.

← Strategy Analysis  ·  Service Lines  ·  IE Independents  ·  Read the full 25,000-word engagement →

Method. Nine strategy archetypes (ambulatory platform, senior MA risk, transparent-price surgical destination, decentralized hospital, DTC consumer/longevity, payvider flip, anti-Optum physician platform, serious-illness continuum, AI-native lean hospital) developed by independent teams with mandatory rules: bridge from −$16M net of new overhead, no double-counting, named external capital, steady-state margin vs. industry benchmark, honest ceilings, what-we-stop-doing, and a 3-year copyability test. Each attacked by a financial-realism, market/competitive, and regulatory/execution panel; failures repaired against the specific objections or replaced across three rounds until five survived (9 → 1; +5 repairs → 2; +4 repairs → 5). Grounded in the project's verified datasets (HCAI leakage, CMS Care Compare ×21 hospitals, the 188-group independent census, LEHD/ACS commuting, CDC PLACES, DOL 5500, IRS 990). Planning analysis — not actuarial, legal, or investment advice.